Medcenter One — Bismarck, North Dakota

Medcenter One is a clinical research site located in Bismarck, North Dakota, United States 58506.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Medcenter One has participated in 3 clinical trials.

Therapeutic areas: Rheumatoid Arthritis, Coronary Artery Disease, Metastatic Colorectal Cancer.

Sponsors: Genentech, Inc., Alexion Pharmaceuticals, Inc., Morphotek.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bismarck

Browse all research sites in North Dakota · View every site in Bismarck

• University of Mary
• Cancer Care Center at Medcenter One Hospital
• Medcenter One Hospital Cancer Care Center
• University of North Dakota Center for Family Medicine, Bismarck Clinic
• Ohio State University-Telemedicine
• Sanford Bismarck Medical Center
• Mid-Dakota Clinic PC
• Bismarck Cancer Center
• St. Alexius Medical Center Cancer Center
• Medcenter One Health System
• Mid Dakota Clinic
• Saint Alexius Medical Center

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medcenter One?

Medcenter One has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medcenter One conducted?

Medcenter One has 3 clinical trials on record. Their work covers Rheumatoid Arthritis, Coronary Artery Disease, Metastatic Colorectal Cancer.

Is Medcenter One accredited by Crixeo Clinical Trials?

Medcenter One has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medcenter One?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.